{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T09:52:22Z","timestamp":1768816342230,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Natural Science Foundation of Shannxi Province","award":["2019JM-144"],"award-info":[{"award-number":["2019JM-144"]}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81700474"],"award-info":[{"award-number":["81700474"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Pudong Hospital","award":["YJRCJJ201801"],"award-info":[{"award-number":["YJRCJJ201801"]}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["20ZR1450100"],"award-info":[{"award-number":["20ZR1450100"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To determine the population attributable fraction (PAF) of fatty liver disease (FLD) for type 2 diabetes mellitus (T2DM) and compare it to the PAFs of other metabolic abnormalities.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a 10-year retrospective cohort study of 33,346 individuals in Karamay Central Hospital of Xinjiang. Individuals were followed up for T2DM occurrence based on FBS. The PAFs of FLD were calculated generally and respectively in different sex and age groups. A comparison of the PAF of FLD and that of other metabolic abnormalities, as well as the PAFs of FLD in different groups classified based on age and sex, was performed using Cox regression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During an average follow-up period of 3.71 years, 1486 T2DM were diagnosed. The incidence density of T2DM was 1.2\/100 person-years, and cumulative incidence rate was 4456.31\/100,000 person-years. Partial PAF (PAF<jats:sub>p<\/jats:sub>) of FLD in the entire population was 23.11%. In the male population, PAF<jats:sub>p<\/jats:sub> was higher at 30\u201340 years old. In the female population, it was higher when age\u2009\u2265\u200960 years old. In multivariable Cox regression model, FLD, male sex, age\u2009\u2265\u200945 years old, overweight, hypertriglyceridaemia, and systolic hypertension were independent risk factors for T2DM, with corresponding PAF<jats:sub>p<\/jats:sub> of 25.00%, 24.99%, 36.47%, 24.96%, 5.71%, and 6.76%, respectively. Age\u2009\u2265\u200945 years old showed the highest PAFp and adjusted hazard ratio, followed by FLD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>FLD contributes more to T2DM incidence than other metabolic disorders. Particular attention should be given to male populations of 30\u201340 and female populations above 60 for FLD prevention and treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-023-01433-z","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T10:02:32Z","timestamp":1695117752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Population attributable fractions of fatty liver disease for type 2 diabetes Mellitus"],"prefix":"10.1186","volume":"23","author":[{"given":"Jingyuan","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longyun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longbao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yatao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajun","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaoyun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyi","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,19]]},"reference":[{"issue":"8","key":"1433_CR1","doi-asserted-by":"publisher","first-page":"668","DOI":"10.19538\/j.nk2021080106]","volume":"41","author":"Chinese Diabetes Society","year":"2021","unstructured":"Chinese Diabetes Society. Guidelines for the prevention and control of type 2 diabetes in China (2020 Edition). Zhongguo shiyongneike zazhi = chinese. J Practical Intern Med. 2021;41(8):668\u201395. https:\/\/doi.org\/10.19538\/j.nk2021080106].","journal-title":"J Practical Intern Med"},{"issue":"1","key":"1433_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3760\/cma.j.cn112138-20211027-00751]","volume":"61","author":"Chinese Elderly Type 2 Diabetes Prevention and Treatment of Clinical Guidelines Writing Group","year":"2022","unstructured":"Chinese Elderly Type 2 Diabetes Prevention and Treatment of Clinical Guidelines Writing Group. Clinical guidelines for prevention and treatment of type 2 diabetes mellitus in the elderly in China (2022 Edition). Zhonghua nei ke za zhi. 2022;61(1):12\u201350. https:\/\/doi.org\/10.3760\/cma.j.cn112138-20211027-00751].","journal-title":"Zhonghua nei ke za zhi"},{"issue":"1","key":"1433_CR3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. The diagnosis and management of non-alcoholic fatty liver disease: practice guidance from the American Association for the study of Liver Diseases. Hepatology. 2018;67(1):328\u201357. [DOI: 10.1002\/hep.29367] [PMID: 28714183].","journal-title":"Hepatology"},{"issue":"11","key":"1433_CR4","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.3390\/nu9111220","volume":"9","author":"CC Chiu","year":"2017","unstructured":"Chiu CC, Ching YH, Li YP, Liu JY, Huang YT, Huang YW, Yang SS, Huang WC, Chuang HL. Non-alcoholic fatty liver disease is exacerbated in high-fat diet-fed gnotobiotic mice by colonization with the gut microbiota from patients with non-alcoholic steatohepatitis. Nutrients. 2017;9(11):1220. [DOI: 10.3390\/nu9111220] [PMID: 29113135].","journal-title":"Nutrients"},{"issue":"8","key":"1433_CR5","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","volume":"5","author":"Q Ye","year":"2020","unstructured":"Ye Q, Zou B, Yeo YH, Li J, Huang DQ, Wu Y, Yang H, Liu C, Kam LY, Tan XXE, Chien N, Trinh S, Henry L, Stave CD, Hosaka T, Cheung RC, Nguyen MH. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(8):739\u201352. https:\/\/doi.org\/10.1016\/S2468-1253(20)30077-7. Epub 2020 May 12. PMID: 32413340.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"1433_CR6","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/hep.28356","volume":"63","author":"J Boursier","year":"2016","unstructured":"Boursier J, Mueller O, Barret M, Machado M, Fizanne L, Araujo-Perez F, Guy CD, Seed PC, Rawls JF, David LA, Hunault G, Oberti F, Cal\u00e8s P, Diehl AM. The severity of non-alcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology. 2016;63(3):764\u201375. [DOI: 10.1002\/hep.28356] [PMID: 26600078].","journal-title":"Hepatology"},{"key":"1433_CR7","doi-asserted-by":"publisher","unstructured":"Perumpail BJ, Khan MA, Yoo ER, Cholankeril G, Kim D, Ahmed A. Clinical epidemiology and disease burden of non-alcoholic fatty liver disease. World J Gastroenterol 2017; 23(47): 8263\u20138276 [DOI: https:\/\/doi.org\/10.3748\/wjg.v23.i47.8263] [PMID: 29307986].","DOI":"10.3748\/wjg.v23.i47"},{"issue":"3","key":"1433_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2337\/dc16-1787","volume":"40","author":"F Bril","year":"2017","unstructured":"Bril F, Cusi K. Management of non-alcoholic fatty liver disease in patients with type 2 diabetes: a call to action. Diabetes Care. 2017;40(3):419\u201330. [DOI: 10.2337\/dc16-1787] [PMID: 28223446].","journal-title":"Diabetes Care"},{"issue":"2","key":"1433_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/13543784.2020.1715940","volume":"29","author":"J Colca","year":"2020","unstructured":"Colca J. NASH (non-alcoholic steatohepatitis), diabetes, and macrovascular disease: multiple chronic conditions and a potential treatment at the metabolic root. Expert Opin Investig Drugs. 2020;29(2):191\u20136. [DOI: 10.1080\/13543784.2020.1715940] [PMID: 31928475].","journal-title":"Expert Opin Investig Drugs"},{"issue":"9","key":"1433_CR10","doi-asserted-by":"publisher","first-page":"571","DOI":"10.36290\/vnl.2019.098","volume":"65","author":"R Br\u016fha","year":"2019","unstructured":"Br\u016fha R. Non-alcoholic fatty liver disease. Vnitr Lek. 2019;65(9):571\u20135. [PMID: 31635468].","journal-title":"Vnitr Lek"},{"issue":"3","key":"1433_CR11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1590\/s0004-2803.201900000-45","volume":"56","author":"ER Parise","year":"2019","unstructured":"Parise ER. Non-alcoholic fatty liver disease (NAFLD), more than a liver disease. Arq gastroenterol. 2019;56(3):243\u20135. [DOI: 10.1590\/S0004-2803.201900000-45] [PMID: 31633718].","journal-title":"Arq gastroenterol"},{"issue":"2","key":"1433_CR12","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.dsx.2018.11.065","volume":"13","author":"M Nwankwo","year":"2019","unstructured":"Nwankwo M, Okamkpa JC, Danborno B. Association between high blood pressure with risk of type 2 diabetes, metabolic syndrome and its predictors: a cross-sectional study. Diabetes Metab Syndr. 2019;13(2):1549\u201354. 11.065] [PMID: 31336520].","journal-title":"Diabetes Metab Syndr"},{"issue":"9","key":"1433_CR13","doi-asserted-by":"publisher","first-page":"e19236","DOI":"10.1097\/MD.0000000000019236","volume":"99","author":"L Yin","year":"2020","unstructured":"Yin L, Zhang D, Ren Q, Su X, Sun Z. Prevalence and risk factors of diabetic retinopathy in diabetic patients: a community based cross-sectional study. Medicine. 2020;99(9):e19236. [DOI: 10.1097\/MD.0000000000019236] [PMID: 32118727].","journal-title":"Medicine"},{"issue":"10","key":"1433_CR14","doi-asserted-by":"publisher","first-page":"e1002953","DOI":"10.1371\/journal.pmed.1002953]","volume":"16","author":"NYH Ng","year":"2019","unstructured":"Ng NYH, Jiang G, Cheung LP, Zhang Y, Tam CHT, Luk AOY, Quan J, Lau ESH, Yau TTL, Chan MHM, Ho CS, Lim CKP, Ozaki R, Huang J, Liu KH, Tam WH, Sahota DS, Chu WCW, Goggins W, Woo J, Li TC, Chow CC, Chan JCN, Ma RCW. Progression of glucose intolerance and cardiometabolic risk factors over a decade in chinese women with polycystic ovary syndrome: a case-control study. PLoS Med. 2019;16(10):e1002953. https:\/\/doi.org\/10.1371\/journal.pmed.1002953]. [PMID: 31652273].","journal-title":"PLoS Med"},{"issue":"18","key":"1433_CR15","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.2174\/1381612825666190708192134","volume":"25","author":"N Katsiki","year":"2019","unstructured":"Katsiki N, Anagnostis P, Kotsa K, Goulis DG, Mikhailidis DP. Obesity, metabolic syndrome and the risk of microvascular complications in patients with diabetes mellitus. Curr Pharm Des. 2019;25(18):2051\u20139. [DOI: 10.2174\/1381612825666190708192134] [PMID: 31298151].","journal-title":"Curr Pharm Des"},{"issue":"7\u20138","key":"1433_CR16","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/sim.3792","volume":"29","author":"MA Laaksonen","year":"2010","unstructured":"Laaksonen MA, H\u00e4rk\u00e4nen T, Knekt P, Virtala E, Oja H. Estimation of population attributable fraction (PAF) for disease occurrence in a cohort study design. Stat Med. 2010;29(7\u20138):860\u201374. [DOI: 10.1002\/sim.3792] [PMID: 20213711].","journal-title":"Stat Med"},{"issue":"2","key":"1433_CR17","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/hep.31040","volume":"72","author":"CS Alvarez","year":"2020","unstructured":"Alvarez CS, Graubard BI, Thistle JE, Jessica LP, McGlynn KA. Attributable fractions of NAFLD for mortality in the United States: results from NHANES III with 27 years of follow-up. Hepatology. 2020;72(2):430\u201340. [DOI: 10.1002\/hep.31040] [PMID: 31733165].","journal-title":"Hepatology"},{"issue":"9403","key":"1433_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"WHO Expert Consultation","year":"2004","unstructured":"WHO Expert Consultation. Appropriate body-mass index for asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157\u201363. [DOI: 10.1016\/S0140-6736(03)15268-3] [PMID: 14726171].","journal-title":"Lancet"},{"issue":"7","key":"1433_CR19","first-page":"579","volume":"39","author":"LS Liu","year":"2011","unstructured":"Liu LS. Writing Group of 2010 chinese guidelines for the management of hypertension. [2010 chinese guidelines for the management of hypertension]. Zhonghua Xin Xue Guan Bing Za Zhi = Chin J Cardiovasc Dis. 2011;39(7):579\u2013615. Chinese. [PMID: 22088239].","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi = Chin J Cardiovasc Dis"},{"issue":"5","key":"1433_CR20","first-page":"390","volume":"35","author":"Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults","year":"2007","unstructured":"Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults. Chinese guidelines on prevention and treatment of dyslipidemia in adults. Zhonghua Xin Xue Guan Bing Za Zhi = Chin J Cardiovasc Dis. 2007;35(5):390\u2013419. [PMID: 17711682].","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi = Chin J Cardiovasc Dis"},{"issue":"3","key":"1433_CR21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/GME.0000000000001200","volume":"26","author":"Y Ren","year":"2019","unstructured":"Ren Y, Zhang M, Liu Y, Sun X, Wang B, Zhao Y, Liu D, Liu X, Zhang D, Liu F, Cheng C, Liu L, Chen X, Zhou Q, Hu D. Association of menopause and type 2 diabetes mellitus. Menopause. 2019;26(3):325\u201330. [DOI: 10.1097\/GME.0000000000001200] [PMID: 30130291].","journal-title":"Menopause"},{"issue":"1","key":"1433_CR22","doi-asserted-by":"publisher","first-page":"155DOI","DOI":"10.1186\/s12944-019-1091-7]","volume":"18","author":"Q Li","year":"2019","unstructured":"Li Q, Wang X, Ni Y, Hao H, Liu Z, Wen S, Shao X, Wu X, Yu W, Hu W. Epidemiological characteristics and risk factors of T2DM in chinese premenopausal and postmenopausal women. Lipids Health Dis. 2019;18(1):155DOI. https:\/\/doi.org\/10.1186\/s12944-019-1091-7]. [PMID: 31315681].","journal-title":"Lipids Health Dis"},{"issue":"12","key":"1433_CR23","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1210\/jc.2015-2546","volume":"100","author":"B Fenske","year":"2015","unstructured":"Fenske B, Kische H, Gross S, Wallaschofski H, V\u00f6lzke H, D\u00f6rr M, Nauck M, Keevil BG, Brabant G, Haring R. Endogenous androgens and sex hormone-binding globulin in women and risk of metabolic syndrome and type 2 diabetes. J Clin Endocrinol Metab. 2015;100(12):4595\u2013603. [DOI: 10.1210\/jc.2015-2546] [PMID: 26445113].","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1433_CR24","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1210\/er.2015-1137","volume":"37","author":"A Kautzky-Willer","year":"2016","unstructured":"Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37(3):278\u2013316. [DOI: 10.1210\/er.2015-1137] [PMID: 27159875].","journal-title":"Endocr Rev"},{"issue":"9","key":"1433_CR25","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrendo.2017.56","volume":"13","author":"RCR Meex","year":"2017","unstructured":"Meex RCR, Watt MJ, Hepatokines. Linking non-alcoholic fatty liver disease and insulin resistance. Nat Rev Endocrinol. 2017;13(9):509\u201320. [DOI: 10.1038\/nrendo.2017.56] [PMID: 28621339].","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"1433_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3760\/cma.j.issn.1007-3418.2018.03.008]","volume":"26","author":"National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association, Fatty Liver Expert Committee, Chinese Medical Doctor Association National Workshop on Fatty Liver and Alcoholic Liver Disease","year":"2018","unstructured":"National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association, Fatty Liver Expert Committee, Chinese Medical Doctor Association National Workshop on Fatty Liver and Alcoholic Liver Disease. Guidelines of prevention and treatment for non-alcoholic fatty liver disease: a 2018 update. Zhonghua Ganzangbing Zazhi = Chin J Hepatol. 2018;26(3):195\u2013203. https:\/\/doi.org\/10.3760\/cma.j.issn.1007-3418.2018.03.008]. [PMID: 29804393].","journal-title":"Zhonghua Ganzangbing Zazhi = Chin J Hepatol"},{"issue":"12","key":"1433_CR27","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S2213-8587(18)30204-3","volume":"6","author":"AP Hills","year":"2018","unstructured":"Hills AP, Arena R, Khunti K, Yajnik CS, Jayawardena R, Henry CJ, Street SJ, Soares MJ, Misra A. Epidemiology and determinants of type 2 diabetes in South Asia. Lancet Diabetes Endocrinol. 2018;6(12):966\u201378. [DOI: 10.1016\/S2213-8587(18)30204-3] [PMID: 30287102].","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"1433_CR28","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nm.4350","volume":"23","author":"MP Czech","year":"2017","unstructured":"Czech MP. Insulin action and resistance in obesity and type 2 diabetes. Nat Med. 2017;23(7):804\u201314. [DOI: 10.1038\/nm.4350] [PMID: 28697184].","journal-title":"Nat Med"},{"issue":"3","key":"1433_CR29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3760\/cma.j.issn.1007-3418.2019.03.007]","volume":"27","author":"JY Xu","year":"2019","unstructured":"Xu JY, Shao Y, Lu XL, Deng J, Li XL, Shi HT. [Analysis of influencing factors and causes of death in elderly residents with non-alcoholic fatty liver disease]. Zhonghua Ganzangbing Zazhi = Chin J Hepatol. 2019;27(3):204\u20139. https:\/\/doi.org\/10.3760\/cma.j.issn.1007-3418.2019.03.007]. [PMID: 30929337].","journal-title":"Zhonghua Ganzangbing Zazhi = Chin J Hepatol"},{"issue":"3","key":"1433_CR30","doi-asserted-by":"publisher","first-page":"758","DOI":"10.2337\/diacare.26.3.758]","volume":"26","author":"MJ McNeely","year":"2003","unstructured":"McNeely MJ, Boyko EJ, Leonetti DL, Kahn SE, Fujimoto WY. Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans. Diabetes Care. 2003;26(3):758\u201363. https:\/\/doi.org\/10.2337\/diacare.26.3.758]. [PMID: 12610034].","journal-title":"Diabetes Care"},{"issue":"4","key":"1433_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.7326\/0003-4819-137-4-200208200-00011]","volume":"137","author":"RG Barr","year":"2002","unstructured":"Barr RG, Nathan DM, Meigs JB, Singer DE. Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med. 2002;137(4):263\u201372. https:\/\/doi.org\/10.7326\/0003-4819-137-4-200208200-00011]. [PMID: 12186517].","journal-title":"Ann Intern Med"},{"key":"1433_CR32","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.2337\/dc15-S005","volume":"38","author":"American Diabetes Association","year":"2015","unstructured":"American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2015;38:S8\u2013S16. https:\/\/doi.org\/10.2337\/dc15-S005. [PMID: 25537714].","journal-title":"Diabetes Care"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-023-01433-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-023-01433-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-023-01433-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T21:30:53Z","timestamp":1700429453000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-023-01433-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1433"],"URL":"https:\/\/doi.org\/10.1186\/s12902-023-01433-z","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,19]]},"assertion":[{"value":"11 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods in this study were carried out in accordance with relevant guidelines and regulations. The study was approved by the Ethics Committee of the Karamay Center Hospital of Xinjiang. All participants in had signed the informed consent form before medical check-up in Karamay Center Hospital of Xinjiang. Also, this study is a retrospective cohort and all clinical data was anonymous.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"201"}}